DisclosureLens
HackingHealthcareTechnologyHealthcareStolen CredentialsCapture Stored DataData ExfiltratedCustomer Data InvolvedDelayed DiscoveryIdentity (basic)Health (basic)PHIMediumContained

REGENERON PHARMACEUTICALS, INC.

bd_2b4ab18fae66401b · schema v1 · pii pii-v1

Severity

Medium

Discovered

Feb 21, 2024

Filed

May 22, 2024

To disclose

13 weeks

Affected

13,958state residents only

Linked

3 filings

Confidence

68%
Full breach record for REGENERON PHARMACEUTICALS, INC.2 incidents on file

Regeneron Pharmaceuticals, Inc. experienced a data breach via its third-party vendor, The Lash Group, LLC. Unauthorized access occurred on Feb 21, 2024, involving exfiltration of PII and PHI (names, DOB, addresses, health diagnoses, prescriptions) from ~13,958 individuals. Lash Group detected the breach on Feb 21, 2024, and Regeneron was notified on April 18, 2024. Notifications were sent in May 2024.

Washington clock WA AG >30d13 weeks discovery → filing

Incident timeline

discovery → filing · 13 weeks / 91 days

Feb 21, 2024

Discovered

May 22, 2024

Filed

vs. sector median

+2 wks slower

This filing is one of 3 about the same incident.View merged incident

Linked disclosures

Why this link?

Regulatory filings (2) · sorted by filing gap

Filing propagation · 3 filings · 3 states

View merged incident ↗
Indiana State AGMay 22 · first
Montana State AGMay 22 · first
Washington State AGMay 22 · first · this page

Evidence ladder

Leak-site claim

Attacker assertion only. Establishes: claim date, group, alleged victim.

Press / market report

Unlocks: incident narrative, operational impact. Still no compliance clock.

State AG / regulator filingThis record

Unlocks: discovery date, data types, affected count, compliance clock.

SEC 8-K / victim statement

Unlocks: materiality, stated response, full audit trail. Ceiling removed.